The Pathogenicity of MERS-CoV, SARS-CoV and SARS-CoV-2: A Comparative Overview

被引:0
|
作者
Shashank, Patil M. [1 ]
Prithvi, Shirahatti S. [2 ]
Ramith, Ramu [1 ]
机构
[1] JSS Acad Higher Educ & Res, Sch Life Sci, Dept Biotechnol & Bioinformat, Mysuru 570015, Karnataka, India
[2] Teresian Coll, Dept Biotechnol, Mysuru 570011, Karnataka, India
来源
RESEARCH JOURNAL OF BIOTECHNOLOGY | 2021年 / 16卷 / 01期
关键词
SARS-CoV; MERS-CoV; Pathogenesis; Transmission; Infection; COVID-19; INFECTION; CORONAVIRUS; INHIBITORS; EVOLUTION; ORIGIN;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The ongoing detrimental consequences of SARS-CoV-2 or COVID-19 are attributable to its remarkable pathogenesis and modes of transmission. Originating from a common ancestor of the previous coronavirus outbreaks, MERS-CoV and SARS-CoV-1, the former has been evolved in terms of its pathogenic mechanisms, routes of transmission and the extent of infection. The comprehensive evaluation of these modifications at the molecular level would reveal astonishing details about the extensive lethality of the current SARS-CoV-2 outbreak. Further, these details can be utilized for the development of effective and specific treatment methods. This review elaborates the comparative assessment of the viral characteristics of coronaviruses: MERS-CoV, SARS-CoV-1 and SARSCoV-2. With the comparative account, the study endeavours to leave a clear picture explaining the reason behind the extensive lethality of the current SARS-CoV-2 pandemic.
引用
收藏
页码:182 / 192
页数:11
相关论文
共 50 条
  • [21] SARS-CoV,MERS-CoV,SARS-CoV-2冠状病毒研究进展
    陆湛
    符兆胤
    黄志卫
    黄克刚
    高云兵
    王华
    分子影像学杂志, 2020, 43 (01) : 174 - 178
  • [22] Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
    Fani, Mona
    Teimoori, Ali
    Ghafari, Shokouh
    FUTURE VIROLOGY, 2020, 15 (05) : 317 - 323
  • [23] Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
    Sessa, Francesco
    Salerno, Monica
    Pomara, Cristoforo
    MEDICINA-LITHUANIA, 2021, 57 (04):
  • [24] Convalescent plasma as a therapeutic agent for SARS-CoV, MERS-CoV and SARS-CoV-2: A scoping review
    Mariamenatu, Abeba Haile
    Abdu, Emebet Mohammed
    JOURNAL OF ACUTE DISEASE, 2021, 10 (02) : 47 - 56
  • [25] Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV
    Priya, V. K.
    Rath, Satish Prasad
    Abraham, Parvin
    PLOS ONE, 2021, 16 (05):
  • [26] SARS-COV和MERS-COV以及SARS-COV-2的研究进展
    董家潇
    李修政
    张忠伟
    严佳栋
    中国病毒病杂志, 2021, 11 (05) : 381 - 387
  • [27] COMPARATIVE HIGHLIGHTS ON MERS-COV, SARS-COV-1, SARS-COV-2, AND NEO-COV
    Goyal, Rajat
    Gautam, Rupesh K.
    Chopra, Hitesh
    Dubey, Ankit Kumar
    Singla, Rajeev K.
    Rayan, Rehab A.
    Kamal, Mohammad Amjad
    EXCLI JOURNAL, 2022, 21 : 1245 - 1272
  • [28] The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
    Nima Hemmat
    Zahra Asadzadeh
    Noora Karim Ahangar
    Hajar Alemohammad
    Basira Najafzadeh
    Afshin Derakhshani
    Amir Baghbanzadeh
    Hossein Bannazadeh Baghi
    Darya Javadrashid
    Souzan Najafi
    Meriadeg Ar Gouilh
    Behzad Baradaran
    Archives of Virology, 2021, 166 : 675 - 696
  • [29] SARS-CoV、MERS-CoV、SARS-CoV-2的基因结构特点与致病机制
    赵澄
    卢芳国
    中国感染控制杂志, 2020, 19 (12) : 1134 - 1139
  • [30] SARS-CoV-2, SARS-CoV, and MERS-CoV encode circular RNAs of spliceosome-independent origin
    Yang, Shaomin
    Zhou, Hong
    Liu, Mingde
    Jaijyan, Dabbu
    Cruz-Cosme, Ruth
    Ramasamy, Santhamani
    Subbian, Selvakumar
    Liu, Dongxiao
    Xu, Jiayu
    Niu, Xiaoyu
    Li, Yaolan
    Xiao, Lizu
    Tyagi, Sanjay
    Wang, Qiuhong
    Zhu, Hua
    Tang, Qiyi
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (07) : 3203 - 3222